CA
EXEL icon

Calton & Associates’s Exelixis EXEL Stock Holding History

Calton & Associates’s Portfolio EXEL Stock Details EXEL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-9,137
Closed -$207K – 276
2022
Q1 		$207K Buy
+9,137
New +$178K 0.06% 326
2020
Q4 		– Sell
-8,237
Closed -$201K – 392
2020
Q3 		$201K Sell
8,237
-235
-3% -$5.49K 0.04% 319
2020
Q2 		$201K Buy
+8,472
New +$196K 0.04% 309

Other funds holding EXEL

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
MG
Meditor Group Hamilton, Bermuda $48.1M AUM 38.67% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Calton & Associates's EXEL Position: Q2 2022 in Review

Calton & Associates sold out of Exelixis (EXEL) in Q2 2022, closing a stake of 9,137 shares — an estimated $207K sold.

Calton & Associates first reported a position in EXEL in Q2 2020 and held it in 3 quarters. The position peaked at $207K in Q1 2022. 373 funds tracked by Wall St. Rank hold EXEL as of Q2 2022.

  • Calton & Associates reported no remaining Exelixis position as of Q2 2022 after selling out during the quarter.
  • Calton & Associates sold 9,137 Exelixis shares in Q2 2022, an estimated $207K.
  • Calton & Associates first reported a position in Exelixis in Q2 2020 and held it in 3 quarters.
  • Calton & Associates's Exelixis position peaked at $207K in Q1 2022.
  • 373 funds tracked by Wall St. Rank held Exelixis as of Q2 2022.

Based on Calton & Associates's 13F filing for Q2 2022, filed 12 Jul 2022.